[Studies on antimicrobial effects of local anesthetics. Part 1. The effect of lidocaine hydrochloride on the oral microorganisms]. 1980

K Hirata, and Y Takahashi, and K Ota, and M Sato, and K Sawami, and H Nitta, and I Namikawa

UI MeSH Term Description Entries
D008012 Lidocaine A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE. Lignocaine,2-(Diethylamino)-N-(2,6-Dimethylphenyl)Acetamide,2-2EtN-2MePhAcN,Dalcaine,Lidocaine Carbonate,Lidocaine Carbonate (2:1),Lidocaine Hydrocarbonate,Lidocaine Hydrochloride,Lidocaine Monoacetate,Lidocaine Monohydrochloride,Lidocaine Monohydrochloride, Monohydrate,Lidocaine Sulfate (1:1),Octocaine,Xylesthesin,Xylocaine,Xylocitin,Xyloneural
D009055 Mouth The oval-shaped oral cavity located at the apex of the digestive tract and consisting of two parts: the vestibule and the oral cavity proper. Oral Cavity,Cavitas Oris,Cavitas oris propria,Mouth Cavity Proper,Oral Cavity Proper,Vestibule Oris,Vestibule of the Mouth,Cavity, Oral
D002176 Candida albicans A unicellular budding fungus which is the principal pathogenic species causing CANDIDIASIS (moniliasis). Candida albicans var. stellatoidea,Candida stellatoidea,Dematium albicans,Monilia albicans,Myceloblastanon albicans,Mycotorula albicans,Parasaccharomyces albicans,Procandida albicans,Procandida stellatoidea,Saccharomyces albicans,Syringospora albicans
D000766 Anesthesia, Dental A range of methods used to reduce pain and anxiety during dental procedures. Dental Anesthesia
D000890 Anti-Infective Agents Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. Anti-Infective Agent,Anti-Microbial Agent,Antimicrobial Agent,Microbicide,Microbicides,Anti-Microbial Agents,Antiinfective Agents,Antimicrobial Agents,Agent, Anti-Infective,Agent, Anti-Microbial,Agent, Antimicrobial,Agents, Anti-Infective,Agents, Anti-Microbial,Agents, Antiinfective,Agents, Antimicrobial,Anti Infective Agent,Anti Infective Agents,Anti Microbial Agent,Anti Microbial Agents
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001419 Bacteria One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive. Eubacteria

Related Publications

K Hirata, and Y Takahashi, and K Ota, and M Sato, and K Sawami, and H Nitta, and I Namikawa
June 1970, The Journal of infectious diseases,
K Hirata, and Y Takahashi, and K Ota, and M Sato, and K Sawami, and H Nitta, and I Namikawa
June 1950, Current science,
K Hirata, and Y Takahashi, and K Ota, and M Sato, and K Sawami, and H Nitta, and I Namikawa
June 1950, Current science,
K Hirata, and Y Takahashi, and K Ota, and M Sato, and K Sawami, and H Nitta, and I Namikawa
March 1962, The Annals of otology, rhinology, and laryngology,
K Hirata, and Y Takahashi, and K Ota, and M Sato, and K Sawami, and H Nitta, and I Namikawa
July 1976, Ceskoslovenska farmacie,
K Hirata, and Y Takahashi, and K Ota, and M Sato, and K Sawami, and H Nitta, and I Namikawa
September 1990, Annals of emergency medicine,
K Hirata, and Y Takahashi, and K Ota, and M Sato, and K Sawami, and H Nitta, and I Namikawa
January 1954, Therapeutische Umschau. Revue therapeutique,
K Hirata, and Y Takahashi, and K Ota, and M Sato, and K Sawami, and H Nitta, and I Namikawa
November 1969, Die Pharmazie,
K Hirata, and Y Takahashi, and K Ota, and M Sato, and K Sawami, and H Nitta, and I Namikawa
January 1990, European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery,
K Hirata, and Y Takahashi, and K Ota, and M Sato, and K Sawami, and H Nitta, and I Namikawa
January 2009, Journal of oleo science,
Copied contents to your clipboard!